Elutia Inc. (ELUT)
NASDAQ: ELUT · Real-Time Price · USD
0.9410
+0.0807 (9.38%)
At close: Aug 14, 2026, 4:00 PM EDT
0.9500
+0.0090 (0.96%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Elutia Revenue
Elutia had revenue of $2.43M in the quarter ending June 30, 2026, a decrease of -11.65%. This brings the company's revenue in the last twelve months to $12.14M, down -0.34% year-over-year. In the year 2025, Elutia had annual revenue of $12.29M, down -15.03%.
Revenue (ttm)
$12.14M
Revenue Growth
-0.34%
P/S Ratio
3.43
Revenue / Employee
$466,769
Employees
26
Market Cap
41.60M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.29M | -2.17M | -15.03% |
| Dec 31, 2024 | 14.47M | -10.28M | -41.54% |
| Dec 31, 2023 | 24.75M | 896.00K | 3.76% |
| Dec 31, 2022 | 23.85M | -23.54M | -49.68% |
| Dec 31, 2021 | 47.39M | 4.71M | 11.03% |
| Dec 31, 2020 | 42.68M | -219.00K | -0.51% |
| Dec 31, 2019 | 42.90M | 3.86M | 9.90% |
| Dec 31, 2018 | 39.04M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 428.57M |
| Nortech Systems | 124.65M |
| Xtant Medical Holdings | 109.53M |
| TELA Bio | 79.91M |
| SANUWAVE Health | 44.02M |
| QT Imaging Holdings | 26.43M |
| Baird Medical Investment Holdings | 22.54M |
| Sensus Healthcare | 22.53M |
ELUT News
- 1 day ago - Elutia Earnings Call Transcript: Q2 2026 - Transcripts
- 1 day ago - Elutia Earnings release: Q2 2026 - Filings
- 1 day ago - Elutia Slides: Q2 2026 - Filings
- 1 day ago - Elutia Quarterly report: Q2 2026 - Filings
- 1 day ago - Elutia Secures Up to $26 Million to Fund NXT-41x Through Commercial Launch; Reports Second Quarter 2026 Results - GlobeNewsWire
- 1 day ago - Elutia Secures $15 Million Loan Financing from Avenue Capital Group to Fund NXT-41x Launch in $1.5 Billion Plastic and Reconstructive Surgery Market - GlobeNewsWire
- 14 days ago - Elutia to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026 - GlobeNewsWire
- 4 weeks ago - Elutia to sell SimpliDerm business to Cellution Biologics for $11M - TheFly